Retrophin Inc (NASDAQ:RTRX)

26.61
Delayed Data
As of May 22
 -0.09 / -0.34%
Today’s Change
7.85
Today|||52-Week Range
27.55
+117.40%
Year-to-Date

Today’s Trading

Previous close26.70
Today’s open26.67
Day’s range26.05 - 26.96
Volume244,820
Average volume (3 months)602,084
Market cap$930.3M
Dividend yield--
Data as of 4:00pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-86.13%
Earnings growth (this year)+122.76%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)--
P/E ratio160.3
Price/Sales10.87
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ATRAAtara Biotherapeutic...+0.40+1.07%
CHRSCoherus Biosciences ...-0.28-1.11%
OVASOvaScience Inc-0.06-0.19%
BCRXBioCryst Pharmaceuti...+0.12+1.06%
Data as of 4:14pm ET, 05/22/2015

Financials

Last reporting dateMay 11, 2015
EPS forecast (this quarter)$0.56
Annual revenue (last year)$28.2M
Annual profit (last year)-$110.9M
Net profit margin-393.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Stephen J. Aselage
Chief Financial Officer &
Senior Vice President
Laura M. Clague
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers